In the past two years an enormous amount of molecular, genetic, metabolomic and
mechanistic data on the host-bacterium interaction, a healthy gut microbiota and a possible …

Many articles have summarized the changing epidemiology of Clostridium difficile infections
(CDI) in humans, but the emerging presence of C. difficile in foods and animals and possible …

Risk factors of severity (need for surgical intervention, intensive care or fatal outcome) were
analysed in hospital-acquired Clostridium difficile infection (CDI) in a 777-bed community …

Given that Clostridium difficile is not part of the normal human microbiota, if multiple strains
are to accumulate in the colon implies successive exposure events and/or persistent …

Clostridium difficile is a leading nosocomial pathogen and molecular typing is a crucial part
of monitoring its occurrence and spread. Over a three-year period (2013–2015), clinical C …

The diagnosis of Clostridium difficile infection (CDI) requires the detection of toxigenic C.
difficile or its toxins and a clinical assessment. We evaluated the performance of four nucleic …

Objective. To investigate the simultaneous occurrence of more than 1 Clostridium difficile
ribotype in patients' stool samples at the time of diagnostic testing. Methods. Stool samples …

Rapid transmission, high morbidity, and mortality are the features of human infectious
diseases caused by microorganisms, such as bacteria, fungi, and viruses. These diseases …

Virulence of Clostridium difficile is primarily attributed to the large clostridial toxins A and B
while the role of binary toxin (CDT) remains unclear. The prevalence of human strains of C …

Recently, the incidence and severity of Clostridium difficile infection (CDI) has increased. In
cases of fulminant infection, surgery is a viable therapeutic option but associated with high …